Skip to main content
QSI logo

QSI · Quantum-Si Inc

Track QSI — free
$0.77 +0.00 (+0.53%)
Market Cap
$166.57M
Shares
218.88M

QSI metrics

59 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.76
Market cap
$166.57M

Price action

19 metrics
Price change (1W)
-3.7%
Price change (30D)
-0.6%
Price change (3M)
-36.1%
Price change (6M)
-16.4%
Price change (YTD)
-30.8%
Price change (1Y)
-29.5%
Trailing year
Price change (5Y)
-92.3%
52-week high
$2.63
52-week low
$0.70
Change from 52-week high
-71.1%
Change from 52-week low
+8.4%
Annualized volatility
91.8%
Beta
3.7
RSI (14D)
46.0
Price vs SMA 50
-6.4%
Price vs SMA 200
-24.0%
Avg volume (3M)
4.00M
Relative volume
0.4
Average dollar volume
$3.57M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
218.88M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
103.3×
reciprocal yield 1.0%
P / book
0.9
reciprocal yield 108.7%
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-59.4%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
35.0%
Operating margin
-6,887.8%
Trailing 12 months
Net margin
-6,138.3%
Gross profit (TTM)
$562,000
Operating profit (TTM)
−$110.55M
Net income (TTM)
−$98.52M
Trailing 12 months
Diluted EPS (TTM)
$-0.45
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share

Growth

11 metrics
Revenue growth YoY
-41.8%
Year over year
Net income growth YoY
Revenue (TTM)
$1.60M
Trailing 12 months
EPS growth YoY
Shares change YoY
+18.6%
Year over year · more shares
Revenue CAGR (3Y)
Revenue CAGR (5Y)
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-54.7%
Return on assets
-50.9%
Debt / equity
Current ratio
10.0
EBITDA (TTM)
−$105.79M
Free cash flow (TTM)
Quick ratio
9.8
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$23.65M
Total assets
$193.57M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$92.45M
Capital expenditures (TTM)
R&D (TTM)
$55.14M
SG&A (TTM)
$40.59M
Stock compensation (TTM)
$11.13M
R&D / revenue
3,435.5%
Stock compensation / revenue
693.5%

Ownership (13F)

3 metrics
13F filers
141
13F filer change QoQ
-17
Institutional ownership
24.6%

Short interest

3 metrics
Short interest
6.5%
Latest settlement · 4.7 days to cover
Days to cover
4.7d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$71,160
Insider-sentiment score
33 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 1816431 CUSIP 74765K105 13F (30d) 104 filings 103 filers Visit website Investor relations